Bicycle Therapeutics Plc ADR (BCYC) Stock Price, Quote & News

Company Profile

Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expr...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 1223 261 503

Website: www.bicycletherapeutics.com

Address:

Portway Building, Blocks A & B Granta Park Great Abington, Cambridge, United Kingdom

aquira Jul. 31 at 3:02 PM

$BCYC another day another all time low. I am already expecting us to touch between 2.2 to 2.5. Fooook this sheeet. What a waste of time and money

0 · Reply

GangsterX Jul. 30 at 6:58 PM

$BCYC I think the bottom between 3-4. This is another good biotech. Waiting to load it below 3.50 and hold...

0 · Reply

aquira Jul. 29 at 2:36 PM

$BCYC one of the most disappointing stocks out there. Fucking waste of time and money

0 · Reply

Aleexandder Jul. 24 at 11:31 PM

$BCYC Has reported approximately $559.5 million in cash and equivalents as of March 31, 2026!!!

1 · Reply

eladfff Jul. 24 at 4:18 PM

$BCYC Another ugly breakdown on every timeframe. Looks headed to the $2's

2 · Reply

StockScanners Jul. 11 at 10:35 PM

$BCYC keep watch if this holds above 4.30

0 · Reply

tiddyy Jul. 7 at 6:29 PM

$BCYC Wheels starting to turn

0 · Reply

US_Bull Jun. 26 at 3:26 PM

$ADAPY $XBI $BCYC $IOBTQ After several years of bearish sector finally rotation happening to the biosector from overbloated AI and tech.

0 · Reply

tiddyy Jun. 26 at 12:22 PM

$BCYC This magnet $4 is pretty strong lol, at least it seems like a good bottom to accumulate more

0 · Reply

US_Bull Jun. 23 at 1:37 PM

$BCYC Said BCYC was a buy all you need to sdo is to follow the volume I highlighted it below. What a gift to pick shit load of BCYC under 4$ thanks weak hands even more so since the biosector will get pumped with tech and AI selling off money will flow onto the biosector

1 · Reply

Bicycle Therapeutics assumed with an Outperform at Oppenheimer

2026-07-30T11:12:24.000Z - 2 days ago

Bicycle Therapeutics reports Q2 EPS (72c), consensus (58c)

2026-07-30T11:11:57.000Z - 2 days ago

Bicycle Therapeutics sees cash runway into 2030

Jul 30, 2026, 7:00 AM EDT - 2 days ago

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Jul 30, 2026, 7:00 AM EDT - 2 days ago

Bicycle Therapeutics Quarterly report: Q2 2026

Jul 30, 2026, 7:00 AM EDT - 2 days ago

Bicycle Therapeutics Earnings release: Q2 2026

Jul 30, 2026, 7:00 AM EDT - 2 days ago

Bicycle Therapeutics Slides: Corporate presentation

May 21, 2026, 5:00 PM EDT - 2 months ago

Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting

2026-04-30T19:56:40.000Z - 3 months ago

Bicycle Therapeutics price target lowered to $12 from $13 at Jefferies

2026-04-30T13:11:20.000Z - 3 months ago

Bicycle Therapeutics reports Q1 EPS (87c), consensus (65c)

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Bicycle Therapeutics Quarterly report: Q1 2026

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Bicycle Therapeutics Earnings release: Q1 2026

Apr 22, 2026, 8:00 AM EDT - 3 months ago

Bicycle Therapeutics Proxy statement: Proxy filing

Apr 21, 2026, 10:31 AM EDT - 3 months ago

Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting

2026-04-20T12:07:18.000Z - 3 months ago

Bicycle Therapeutics announces updates from EphA2 pipeline at AACR meeting

Apr 20, 2026, 7:00 AM EDT - 3 months ago

Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026

2026-04-08T11:55:49.000Z - 4 months ago

Bicycle Therapeutics price target lowered to $12 from $13 at Morgan Stanley

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Bicycle Therapeutics Proxy statement: Proxy filing

2026-03-18T11:57:07.000Z - 4 months ago

Bicycle Therapeutics price target lowered to $7 from $11 at RBC Capital

2026-03-18T11:45:12.000Z - 4 months ago

Bicycle Therapeutics price target lowered to $36 from $44 at Oppenheimer

Mar 18, 2026, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026

2026-03-18T09:40:52.000Z - 4 months ago

Bicycle Therapeutics price target lowered to $8 from $12 at Citizens

2026-03-17T16:05:50.000Z - 4 months ago

Bicycle Therapeutics price target lowered to $8 from $10 at Truist

2026-03-17T11:08:46.000Z - 4 months ago

Bicycle Therapeutics reports Q4 EPS (29c), consensus (95c)

Mar 17, 2026, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results

Mar 17, 2026, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Earnings release: Q4 2025

Mar 17, 2026, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Annual report: Q4 2025

2026-02-03T12:26:35.000Z - 6 months ago

Bicycle Therapeutics CFO Alethia Young steps down, Travis Thompson succeeds

2026-02-03T12:25:21.000Z - 6 months ago

Bicycle Therapeutics CMO Eric Westin retires, Michael Method succeeds

2026-02-03T12:25:14.000Z - 6 months ago

Bicycle Therapeutics names Michael Skynner chief scientific officer

Feb 3, 2026, 7:00 AM EST - 6 months ago

Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline

Jan 12, 2026, 7:00 AM EST - 7 months ago

Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026

Jan 12, 2026, 7:00 AM EST - 7 months ago

Bicycle Therapeutics Slides: Investor presentation

Dec 16, 2025, 1:00 AM EST - 8 months ago

Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline

2025-11-24T12:35:26.000Z - 8 months ago

Bicycle Therapeutics initiated with a Hold at Truist

Nov 18, 2025, 5:30 AM EST - 9 months ago

Bicycle Therapeutics Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 4:05 PM EST - 9 months ago

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

2025-10-31T10:00:15.000Z - 9 months ago

Bicycle Therapeutics price target raised to $12 from $10 at Citizens JMP

2025-10-31T09:25:16.000Z - 9 months ago

RBC downgrades Bicycle Therapeutics on slow pipeline progress

2025-10-31T01:15:14.000Z - 9 months ago

Bicycle Therapeutics downgraded to Sector Perform at RBC Capital

Oct 30, 2025, 7:00 AM EDT - 9 months ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

Oct 30, 2025, 7:00 AM EDT - 9 months ago

Bicycle Therapeutics Earnings release: Q3 2025

Oct 30, 2025, 7:00 AM EDT - 9 months ago

Bicycle Therapeutics Quarterly report: Q3 2025

Sep 9, 2025, 7:45 AM EDT - 11 months ago

Bicycle Therapeutics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 4:05 PM EDT - 11 months ago

Bicycle Therapeutics Strengthens Board of Directors with New Appointments

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Bicycle Therapeutics Registration statement: Registration Filing

Aug 8, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results

Aug 8, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Quarterly report: Q2 2025

Aug 8, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Earnings release: Q2 2025

Jul 2, 2025, 4:05 PM EDT - 1 year ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 22, 2025, 5:05 PM EDT - 1 year ago

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

May 1, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

May 1, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Quarterly report: Q1 2025

May 1, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Earnings release: Q1 2025

May 1, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Slides: Investor Presentation

Apr 29, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

Apr 23, 2025, 8:00 AM EDT - 1 year ago

Bicycle Therapeutics Proxy statement: Proxy Filing

Apr 8, 2025, 12:45 PM EDT - 1 year ago

Bicycle Therapeutics Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Bicycle Therapeutics Proxy statement: Proxy Filing

Apr 1, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Mar 4, 2025, 9:50 AM EST - 1 year ago

Bicycle Therapeutics Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 25, 2025, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Annual report: Q4 2024

Feb 25, 2025, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Earnings release: Q4 2024

Feb 12, 2025, 10:00 AM EST - 1 year ago

Bicycle Therapeutics Transcript: Oppenheimer 35th Annual Healthcare Life Sciences Conference (Virtual) 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 14, 2025, 8:15 PM EST - 1 year ago

Bicycle Therapeutics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

Jan 12, 2025, 7:00 PM EST - 1 year ago

Bicycle Therapeutics Slides: Investor Presentation

Jan 9, 2025, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 13, 2024, 8:00 AM EST - 1 year ago

Bicycle Therapeutics Transcript: Status Update

Dec 13, 2024, 8:00 AM EST - 1 year ago

Bicycle Therapeutics Press release: Status Update

Dec 13, 2024, 8:00 AM EST - 1 year ago

Bicycle Therapeutics Slides: Status Update

Dec 12, 2024, 6:30 PM EST - 1 year ago

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Dec 10, 2024, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Nov 25, 2024, 5:30 PM EST - 1 year ago

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Nov 19, 2024, 5:30 AM EST - 1 year ago

Bicycle Therapeutics Transcript: Jefferies London Healthcare Conference 2024

Oct 31, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Oct 31, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Quarterly report: Q3 2024

Oct 31, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Earnings release: Q3 2024

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Bicycle Therapeutics Transcript: Status Update

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Bicycle Therapeutics Press release: Status Update

Oct 23, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Sep 18, 2024, 11:30 AM EDT - 2 years ago

Bicycle Therapeutics Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 14, 2024, 3:00 AM EDT - 2 years ago

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Sep 4, 2024, 8:30 AM EDT - 2 years ago

Bicycle Therapeutics Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 21, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Aug 6, 2024, 7:05 AM EDT - 2 years ago

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Aug 6, 2024, 7:00 AM EDT - 2 years ago

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

BSY MASS MLI NJR OFIX QBTS SMMT

Aug 6, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Quarterly report: Q2 2024

Aug 6, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Earnings release: Q2 2024

Jul 22, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Jun 10, 2024, 1:20 PM EDT - 2 years ago

Bicycle Therapeutics Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 23, 2024, 5:05 PM EDT - 2 years ago

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

May 23, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

May 23, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Slides: Investor Presentation

May 2, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

May 2, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Quarterly report: Q1 2024

May 2, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Earnings release: Q1 2024

Apr 24, 2024, 10:05 AM EDT - 2 years ago

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Apr 18, 2024, 8:00 AM EDT - 2 years ago

Bicycle Therapeutics Proxy statement: Proxy Filing

Apr 15, 2024, 8:00 AM EDT - 2 years ago

Bicycle Therapeutics Proxy statement: Proxy Filing

Apr 2, 2024, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Mar 29, 2024, 8:00 AM EDT - 2 years ago

Bicycle Therapeutics Proxy statement: Proxy Filing

Mar 14, 2024, 8:30 AM EDT - 2 years ago

Bicycle Therapeutics Transcript: Barclays 26th Annual Global Healthcare Conference 2024

Mar 5, 2024, 4:35 PM EST - 2 years ago

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Feb 20, 2024, 7:05 AM EST - 2 years ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Feb 20, 2024, 7:00 AM EST - 2 years ago

Bicycle Therapeutics Annual report: Q4 2023

Feb 20, 2024, 7:00 AM EST - 2 years ago

Bicycle Therapeutics Earnings release: Q4 2023

Feb 7, 2024, 7:00 AM EST - 2 years ago

Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 14, 2023, 8:00 AM EST - 2 years ago

Bicycle Therapeutics Transcript: R&D Day 2023

Dec 14, 2023, 8:00 AM EST - 2 years ago

Bicycle Therapeutics Press release: FY 2023

Dec 14, 2023, 7:00 AM EST - 2 years ago

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

Nov 30, 2023, 7:00 AM EST - 2 years ago

Bicycle Therapeutics to Host R&D Day on December 14

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Bicycle Therapeutics Quarterly report: Q3 2023

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Bicycle Therapeutics Earnings release: Q3 2023

Nov 2, 2023, 7:00 AM EDT - 2 years ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

Oct 19, 2023, 7:00 AM EDT - 3 years ago

Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer

Oct 19, 2023, 4:00 AM EDT - 3 years ago

Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director

aquira Jul. 31 at 3:02 PM

$BCYC another day another all time low. I am already expecting us to touch between 2.2 to 2.5. Fooook this sheeet. What a waste of time and money

0 · Reply

GangsterX Jul. 30 at 6:58 PM

$BCYC I think the bottom between 3-4. This is another good biotech. Waiting to load it below 3.50 and hold...

0 · Reply

aquira Jul. 29 at 2:36 PM

$BCYC one of the most disappointing stocks out there. Fucking waste of time and money

0 · Reply

Aleexandder Jul. 24 at 11:31 PM

$BCYC Has reported approximately $559.5 million in cash and equivalents as of March 31, 2026!!!

1 · Reply

eladfff Jul. 24 at 4:18 PM

$BCYC Another ugly breakdown on every timeframe. Looks headed to the $2's

2 · Reply

StockScanners Jul. 11 at 10:35 PM

$BCYC keep watch if this holds above 4.30

0 · Reply

tiddyy Jul. 7 at 6:29 PM

$BCYC Wheels starting to turn

0 · Reply

US_Bull Jun. 26 at 3:26 PM

$ADAPY $XBI $BCYC $IOBTQ After several years of bearish sector finally rotation happening to the biosector from overbloated AI and tech.

0 · Reply

tiddyy Jun. 26 at 12:22 PM

$BCYC This magnet $4 is pretty strong lol, at least it seems like a good bottom to accumulate more

0 · Reply

US_Bull Jun. 23 at 1:37 PM

1 · Reply

eladfff Jun. 23 at 1:32 AM

$BCYC a RAS inhibitor + EphA2 mmae combo would be some kind of drug... Thinking very far ahead

0 · Reply

LabPsycho Jun. 22 at 9:18 PM

$BCYC @US_Bull @telomerase Maybe so. But since the trend is down that suggests to me that somebody is selling en masse even moreso.

1 · Reply

telomerase Jun. 20 at 2:56 PM

$BCYC not quite as good as PCYC 🤪

0 · Reply

Peterson28 Jun. 15 at 11:57 PM

$BCYC Some funds dumped 2-3M shares today. Huge volume.

2 · Reply

US_Bull Jun. 15 at 8:06 PM

$BCYC 3 million shares traded >9x daily average and this board is absoflutely sleeping lol.

1 · Reply

US_Bull Jun. 15 at 4:34 PM

$BCYC Somebody is accumulating en masse!!

0 · Reply

US_Bull Jun. 15 at 4:32 PM

$BCYC Ignore the manipulation instead look at the volume once again surging at >1.5 million!!!

0 · Reply

eladfff Jun. 14 at 6:01 PM

$BCYC Looks terrible on every single timeframe, from 5-minute all the way to monthly candles. Those wanting out continue to throw more weight than anyone wanting in, even all the way down here at $4. Amazing. One of the Bakers' biggest misses ever, putting $600M+ into Kevin Lee and Co's hands at $21.50+/sh.

0 · Reply

LabPsycho Jun. 10 at 7:52 PM

$PBLS looks a lot like $BCYC to me when it came out years ago - then drifted down for years.

0 · Reply

US_Bull Jun. 9 at 6:34 PM

$BCYC Wow dead board nothing for a week I like finding these gems that are under the radar of retail only 945 followers before they start pouring in.

1 · Reply

US_Bull Jun. 9 at 5:33 PM

$BCYC Tons of volume pouring in.

0 · Reply

US_Bull Jun. 9 at 4:29 PM

$BCYC Appears catalysts coming up in H2. I saw that Bakers average is 21$ I like it down here.

0 · Reply

Market Cap	279.94M
Revenue (ttm)	72.59M
Net Income (ttm)	-218.96M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-301.64%
Debt to Equity Ratio	0.00

Volume	336,000
Avg Vol	455,886
Day's Range	N/A - N/A
Shares Out	69.81M
Stochastic %K	11%
Beta	1.55
Analysts	Strong Sell
Price Target	$13.57